Literature DB >> 6697806

Steroid therapy in cardiac sarcoidosis. Increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone.

T Ishikawa, H Kondoh, S Nakagawa, Y Koiwaya, K Tanaka.   

Abstract

A 23-year-old woman was referred to our clinic because of pulmonary edema. The electrocardiogram on admission demonstrated eventual QS pattern in leads 1 and a VL with a poor progression of the R-wave amplitude in the precordial leads. The left ventricle was remarkably dilated with severely diminished contractility. Biopsy of the inguinal lymph nodes, liver, and myocardium confirmed the diagnosis of generalized sarcoidosis. After administration of prednisolone, the left ventricular dimension decreased, and contractility increased concomitant with an improvement of the electrocardiographic abnormalities without any aneurysm forming. We conclude that steroids may keep some jeopardized myocardium viable and that initiation of steroid therapy in an early phase does not result in formation of an aneurysm.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6697806     DOI: 10.1378/chest.85.3.445

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  11 in total

1.  Usefulness of electron microscopy in the diagnosis of cardiac sarcoidosis.

Authors:  G Takemura; Y Takatsu; K Ono; T Miyatake; M Ono; T Izumi; H Fujiwara
Journal:  Heart Vessels       Date:  1995       Impact factor: 2.037

2.  Role of cardiac imaging evaluation of patients with documented or suspected ventricular arrhythmias.

Authors:  Naveen Jonnalagadda; Aditya Jain; Hugh Calkins; Harikrishna Tandri
Journal:  J Nucl Cardiol       Date:  2010 Jan-Feb       Impact factor: 5.952

Review 3.  Current concepts in the management of sarcoidosis.

Authors:  M M Muthiah; J T Macfarlane
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 4.  ¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis.

Authors:  Hiroshi Ohira; Ichizo Tsujino; Keiichiro Yoshinaga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-11       Impact factor: 9.236

Review 5.  Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations.

Authors:  M Sekiguchi; Y Yazaki; M Isobe; M Hiroe
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 6.  Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment.

Authors:  Joseph P Lynch; Jennifer Hwang; Jason Bradfield; Michael Fishbein; Kalyanam Shivkumar; Roderick Tung
Journal:  Semin Respir Crit Care Med       Date:  2014-07-09       Impact factor: 3.119

Review 7.  Sarcoidosis and the heart: A review of the literature.

Authors:  Emrah Ipek; Selami Demirelli; Emrah Ermis; Sinan Inci
Journal:  Intractable Rare Dis Res       Date:  2015-11

8.  Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis.

Authors:  Lars C Gormsen; Nana Louise Christensen; Elisabeth Bendstrup; Lars Poulsen Tolbod; Søren Steen Nielsen
Journal:  J Nucl Cardiol       Date:  2013-10-17       Impact factor: 5.952

9.  Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.

Authors:  Hiroshi Ohira; Ichizo Tsujino; Shinji Ishimaru; Noriko Oyama; Toshiki Takei; Eriko Tsukamoto; Masatake Miura; Shinji Sakaue; Nagara Tamaki; Masaharu Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-15       Impact factor: 9.236

10.  A dual tracer (68)Ga-DOTANOC PET/CT and (18)F-FDG PET/CT pilot study for detection of cardiac sarcoidosis.

Authors:  Lars C Gormsen; Ate Haraldsen; Stine Kramer; Andre H Dias; Won Yong Kim; Per Borghammer
Journal:  EJNMMI Res       Date:  2016-06-17       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.